Surgical Neurology
Volume 69, Issue 1 , Pages 46-50 , January 2008

Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors

  • Mizuhiko Terasaki, MD, PhD

      Affiliations

    • Department of Neurosurgery, Kurume University School of Medicine, Fukuoka 830-0011, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 942 35 3311; fax: +81 942 38 8179.
    • ,
  • Eric Bouffet, MD

      Affiliations

    • Pediatric Brain Tumor Program, Hospital for Sick Children, Toronto, Canada M5G 1X8
    • ,
  • Hiroshi Katsuki, MD

      Affiliations

    • Department of Neurosurgery, Kurume University School of Medicine, Fukuoka 830-0011, Japan
    • ,
  • Shintaro Fukushima, MD

      Affiliations

    • Department of Neurosurgery, Kurume University School of Medicine, Fukuoka 830-0011, Japan
    • ,
  • Minoru Shigemori, MD, PhD

      Affiliations

    • Department of Neurosurgery, Kurume University School of Medicine, Fukuoka 830-0011, Japan

Received 12 January 2007 ,Accepted 18 July 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0090-3019(07)00920-2

doi: 10.1016/j.surneu.2007.07.066

Surgical Neurology
Volume 69, Issue 1 , Pages 46-50 , January 2008

Article Tools

* Image Usage & Resolution